Loading company…
Zennea Technologies makes ZENS, an app-controlled device that reduces chronic snoring and mild sleep apnea.
Founded in 2016 and based in Surrey, Canada, Zennea Technologies Inc. develops ZENS, a therapeutic device positioned under the chin during sleep and controlled by a mobile app. It treats chronic snoring and mild obstructive sleep apnea. The company raised CAD 1 million in seed funding in January 2021 from SOSV, Saltagen Ventures and Nimbus Synergies. It plans to pursue FDA approval through a clinical trial.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in